Invesaro

Stocks Health care ADIA

OTC · Health care

Adia Nutrition, Inc. (ADIA)

Adia Nutrition, Inc. reported revenue of $700.5K in fiscal 2025, up 10,879.7% from a year earlier. It posted a net loss of $395.5K. In fiscal 2025 capital spending exceeded operating cash flow by $192.4K. At June 30, 2026 it held $128.1K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch ADIA in 60 seconds
Price
$0.15
+23.97% on the day · September 25, 2026
52-week range $0.03 to $0.28
Market cap
$14.2M
Revenue (FY2025)
$700.5K
+10,879.7% year on year
Net margin
-56.5%

What Adia Nutrition, Inc. does

Adia Nutrition, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker ADIA.

Revenue and profit by year

Revenue
FY25: $6.4K $6.4K FY25FY25: $700.5K $700.5K FY25
Net income
FY25: -$181.1K -$181.1K FY25FY25: -$395.5K -$395.5K FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$700.5K-$366.5K-$395.5K$0.00-$192.4K
2025$6.4K-$174.7K-$181.1K$0.00-$357.3K

Full financial statements: income, balance sheet and cash flow

Next report expected around October 20, 2026.

Estimated from its filing rhythm: about 68 days after its last report of August 13, 2026, its usual gap. Not a date the company has announced. See the report calendar

Where ADIA ranks in Health care

Revenue$700.5K
#661 of 742 in Health care · Bottom 11%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Adia Nutrition, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 24, 2026
  2. August 17, 2026
  3. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 311% to $485.4K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  4. May 15, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 146% to $176.3K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  5. March 31, 2026
    Annual report 10-K · period to December 31, 2025Revenue rose 10,880% to $700.5K versus the prior year; diluted EPS $0.00 versus $0.00.
  6. December 5, 2025
  7. June 24, 2024
  8. June 21, 2024
  9. June 18, 2024
  10. June 10, 2024

Recent insider filings (Forms 3, 4 and 144): 10, the latest on January 3, 2012. Insider transactions on SEC

All filings on SEC EDGAR

Questions about ADIA

What does Adia Nutrition, Inc. do?

Adia Nutrition, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker ADIA.

Is Adia Nutrition, Inc. profitable?

No. In fiscal 2025 it reported a net loss of $395.5K on revenue of $700.5K.

How much revenue does Adia Nutrition, Inc. make?

In fiscal 2025 Adia Nutrition, Inc. reported revenue of $700.5K. That is 10,879.7% more than a year earlier.

When did Adia Nutrition, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from August 24, 2026.

Similar companies

Compare ADIA with

Compare ADIA with any company

Follow ADIA

Get an email when Adia Nutrition, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow ADIA: get an email when it files

Where the numbers come from

Financial figures are the values Adia Nutrition, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.